| padmakara |
| (Member) |
| 11/04/03 02:07 PM |
 Re: New OP in R&D phase consider CII's
|
Quote:
a) Schedule II substances
Except when dispensed directly by a practitioner, other than a pharmacist, to an ultimate user, no controlled substance in schedule II, which is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), may be dispensed without the written prescription of a practitioner, except that in emergency situations, as prescribed by the Secretary by regulation after consultation with the Attorney General, such drug may be dispensed upon oral prescription in accordance with section 503(b) of that Act (21 U.S.C. 353(b)). Prescriptions shall be retained in conformity with the requirements of section 827 of this title. No prescription for a controlled substance in schedule II may be refilled.
Notice, all that is required is no refills, and a written prescription. It says nothing about a physical face-to-face consultation. I've been given CII's in the hospital from specialists that had not physically examined me, were just doing a phone-in consult with staff doc.
Trampy, or plotinus, or someone else knowledgeable, please clarify why everyone seems to think that a face to face consult is required. Urban myth?
